Claim · model-written summary
The imazethapyr–imazamox then propaquizafop sequence matched the maximum weed reduction treatment.
- Taxon
- cluster bean
Cyamopsis tetragonolobat0 - Treatment
- imazethapyr + imazamox (Odyssey) 70 g/ha fb propaquizafop 62.5 g/hae0
- Outcome
- at pare0
- Direction
- at pare0
Not reportedMaterialGeneCompoundOrgan / stageInteractorInteractor roleSecond interactorSecond interactor roleComparatorSettingValueQualifier
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
Verbatim
e0“which was at par with imazethapyr + imazamox (Odyssey) 70 g/ha fb propaquizafop 62.5 g/ha”
t0“cluster bean”
Title
MEENAKSHI SANGWAN; SAMUNDER SINGH; SATYAVAN Indian Journal of Agronomy 2001. doi:10.59797/ija.v61i4.4406
Other claims from this paper (13)
- Intervention effect Pendimethalin reduced weed dry weight by 8590% through 30 DAS.
- Observation The pendimethalin weed dry-weight reduction fell by 2530% at 60 DAS.
- Intervention effect Sequential imazethapyr then propaquizafop reduced weed dry weight by 95% at Kheri Batter.
- Intervention effect Sequential imazethapyr then propaquizafop reduced weed dry weight by 91% at Hisar.
- Observation Imazethapyr plus imazamox had lower efficacy in sandy loam than loamy sand.
- Intervention effect The imazethapyr then propaquizafop sequence had highest seed yield at Kheri Batter.
- Intervention effect The imazethapyr then propaquizafop sequence had highest net returns at Kheri Batter.
- Intervention effect The imazethapyr plus imazamox then propaquizafop sequence had highest seed yield at Kheri Batter.
- Intervention effect The imazethapyr plus imazamox then propaquizafop sequence had highest net returns at Kheri Batter.
- Intervention effect The imazethapyr then propaquizafop sequence had highest seed yield at Hisar.
- Intervention effect The imazethapyr then propaquizafop sequence had highest net returns at Hisar.
- Intervention effect At Hisar, the imazethapyr plus imazamox sequence had lower yield.
- Intervention effect At Hisar, the imazethapyr plus imazamox sequence had lower net returns.